This site is intended for use by U.S. Healthcare Professionals only.

JYNARQUE® (tolvaptan) is indicated to slow kidney function decline in adults at risk of rapidly progressing autosomal dominant polycystic kidney disease (ADPKD).

For your patients at risk
for rapidly progressing ADPKD,

JYNARQUE could change the course of their disease

Hero image